Zein NN - Search Results

1

The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation.

Hanouneh IA, Feldstein AE, McCullough AJ, Miller C, Aucejo F, Yerian L, Lopez R, Zein NN. Hanouneh IA, et al. Among authors: zein nn. Liver Transpl. 2008 Sep;14(9):1287-93. doi: 10.1002/lt.21524. Liver Transpl. 2008. PMID: 18756451 Free article.

2

Hepatocellular Carcinoma in the Setting of Chronic Hepatitis B Virus Infection: Tumor Recurrence and Survival Rates After Liver Transplantation.

Dugum M, Hanouneh I, Lopez R, Aucejo F, Eghtesad B, Zein N. Dugum M, et al. Transplant Proc. 2015 Jul-Aug;47(6):1939-44. doi: 10.1016/j.transproceed.2015.02.021. Transplant Proc. 2015. PMID: 26293077

3

Vascular endothelial growth factor receptor 2 expression in non-tumorous cirrhotic liver is higher when hepatoma is beyond Milan criteria.

Aucejo F, Kim R, Zein N, Quintini C, Uso TD, Lopez R, Eghtesad B, Fung J, Miller C, Yerian L. Aucejo F, et al. Liver Transpl. 2009 Feb;15(2):169-76. doi: 10.1002/lt.21678. Liver Transpl. 2009. PMID: 19177438 Free article.

4

Measurement of CD4+ T-cell function in predicting allograft rejection and recurrent hepatitis C after liver transplantation.

Hashimoto K, Miller C, Hirose K, Diago T, Aucejo F, Quintini C, Eghtesad B, Corey R, Yerian L, Lopez R, Zein N, Fung J. Hashimoto K, et al. Clin Transplant. 2010 Sep-Oct;24(5):701-8. doi: 10.1111/j.1399-0012.2009.01169.x. Clin Transplant. 2010. PMID: 20047619

5

Recurrent hepatitis C after liver transplantation: on-treatment prediction of response to peginterferon/ribavirin therapy.

Hanouneh IA, Miller C, Aucejo F, Lopez R, Quinn MK, Zein NN. Hanouneh IA, et al. Among authors: zein nn. Liver Transpl. 2008 Jan;14(1):53-8. doi: 10.1002/lt.21312. Liver Transpl. 2008. PMID: 18161839 Free article.

6

Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection.

Hanouneh IA, Feldstein AE, Lopez R, Yerian L, Pillai A, Zein CO, Zein NN. Hanouneh IA, et al. Among authors: zein co, zein nn. Clin Gastroenterol Hepatol. 2008 May;6(5):584-9. doi: 10.1016/j.cgh.2008.02.034. Clin Gastroenterol Hepatol. 2008. PMID: 18455698

7

Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.

Askar M, Avery R, Corey R, Lopez R, Thomas D, Pidwell D, Eghtesad B, Miller C, Fung J, Zein NN. Askar M, et al. Among authors: zein nn. Liver Transpl. 2009 Nov;15(11):1557-63. doi: 10.1002/lt.21878. Liver Transpl. 2009. PMID: 19877200 Free article.

8

Monitoring peripheral blood CD4+ adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression.

Alkhouri N, Hanouneh IA, Lopez R, Zein NN. Alkhouri N, et al. Among authors: zein nn. Liver Transpl. 2010 Feb;16(2):155-62. doi: 10.1002/lt.21939. Liver Transpl. 2010. PMID: 20104483 Free article.

9

Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis.

Hanouneh IA, Macaron C, Lopez R, Zein NN, Lashner BA. Hanouneh IA, et al. Among authors: zein nn. Inflamm Bowel Dis. 2012 Feb;18(2):269-74. doi: 10.1002/ibd.21692. Epub 2011 Mar 18. Inflamm Bowel Dis. 2012. PMID: 21425212

10

Neutrophil to lymphocyte ratio: a new marker for predicting steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease.

Alkhouri N, Morris-Stiff G, Campbell C, Lopez R, Tamimi TA, Yerian L, Zein NN, Feldstein AE. Alkhouri N, et al. Among authors: zein nn. Liver Int. 2012 Feb;32(2):297-302. doi: 10.1111/j.1478-3231.2011.02639.x. Epub 2011 Sep 8. Liver Int. 2012. PMID: 22097893

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters